PlainRecalls
FDA Devices Moderate Class II Terminated

Metasul Femoral Head - indicated for total hip arthroplasty for treatment of patient conditions of non-inflammatory degenerative joint disease.

Reported: March 4, 2015 Initiated: December 17, 2014 #Z-1136-2015

Product Description

Metasul Femoral Head - indicated for total hip arthroplasty for treatment of patient conditions of non-inflammatory degenerative joint disease.

Reason for Recall

Potential compromise of the inner sterile tray. If a compromised tray is detected, a delay in surgery may result. If undetected breach in both the inner and outer trays were to occur, and there is contamination present, a periprosthetic infection is possible, which could lead to revision.

Details

Recalling Firm
Zimmer Gmbh
Units Affected
16
Distribution
Domestic: AK, AL, AR, AZ, CA, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MS, MA, MD, ME, MI, MN, MO, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY International: Canada, Japan
Location
Winterthur, N/A

Frequently Asked Questions

What product was recalled?
Metasul Femoral Head - indicated for total hip arthroplasty for treatment of patient conditions of non-inflammatory degenerative joint disease.. Recalled by Zimmer Gmbh. Units affected: 16.
Why was this product recalled?
Potential compromise of the inner sterile tray. If a compromised tray is detected, a delay in surgery may result. If undetected breach in both the inner and outer trays were to occur, and there is contamination present, a periprosthetic infection is possible, which could lead to revision.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 4, 2015. Severity: Moderate. Recall number: Z-1136-2015.